Atlas Trials

Gemcitabine and Cetuximab in Patients With Advanced or Metastatic Biliary Tract Cancer: A Multicenter Phase II Study

Clinical trial NCT00747097 · COMPLETED

Trial details

NCT number
NCT00747097
Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Time to Progression
Start date
2008-09-01
Primary completion
2010-09-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.